News and Trends 6 Aug 2020 €112M Fund Launched to Commercialize UCL’s Gene Therapy Research The leading UK institution University College London and the firm AlbionVC have made the first closing of a €112M (£100M) fund with the aim of investing in UCL research and spinouts with a focus on gene and cell therapy. This is the second so-called UCL Technology Fund and could double the size of the first, […] August 6, 2020 - 2 minutesmins - By Antara Mazumdar Share WhatsApp Twitter Linkedin Email
News and Trends 24 Jul 2020 Swiss Company Raises €23M to Smash Cancer with Bacteria Basel-based T3 Pharmaceuticals has closed its third financing round, worth over €23.3M (CHF 25M), to develop a bacterial cancer therapy. Since T3 Pharma was spun off from the University of Basel in 2015, the firm has raised €37M (CHF 40M). The fundraiser included investors such as Boehringer Ingelheim Venture Fund, Reference Capital, and Wille Finance. […] July 24, 2020 - 2 minutesmins - By Antara Mazumdar Share WhatsApp Twitter Linkedin Email
News and Trends 7 Jul 2020 Hansa Biopharma Gets up to €350M to Make Gene Therapy Work in Resistant Patients Hansa Biopharma has granted an exclusive license to Sarepta Therapeutics for developing and promoting a pretreatment aimed to make a gene therapy to treat muscular dystrophy available to people that are naturally resistant to the treatment. Gene therapy can be used to treat genetic conditions by delivering a healthy copy of the faulty gene using […] July 7, 2020 - 2 minutesmins - By Antara Mazumdar Share WhatsApp Twitter Linkedin Email